ES2540453B1 - Micropartículas con EGF, procedimiento de preparación y uso - Google Patents
Micropartículas con EGF, procedimiento de preparación y uso Download PDFInfo
- Publication number
- ES2540453B1 ES2540453B1 ES201590050A ES201590050A ES2540453B1 ES 2540453 B1 ES2540453 B1 ES 2540453B1 ES 201590050 A ES201590050 A ES 201590050A ES 201590050 A ES201590050 A ES 201590050A ES 2540453 B1 ES2540453 B1 ES 2540453B1
- Authority
- ES
- Spain
- Prior art keywords
- microparticles
- preparation
- egf
- use procedure
- refers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011859 microparticle Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract 2
- 101800003838 Epidermal growth factor Proteins 0.000 abstract 1
- 229920000249 biocompatible polymer Polymers 0.000 abstract 1
- 229940116977 epidermal growth factor Drugs 0.000 abstract 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Micropartículas con EGF, procedimiento de preparación y uso.#La presente invención se refiere a micropartículas que comprenden polímeros biocompatibles y el factor de crecimiento epidérmico. Asimismo, se refiere al método de preparación de dichas micropartículas y a su uso para promover la cicatrización de heridas.
Description
Claims (1)
-
imagen1 imagen2
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382476.5A EP2737895A1 (en) | 2012-11-30 | 2012-11-30 | Microparticles with EGF, method of preparation and use |
PCT/ES2013/070833 WO2014083233A1 (es) | 2012-11-30 | 2013-12-02 | Micropartículas con egf, procedimiento de preparación y uso |
Publications (3)
Publication Number | Publication Date |
---|---|
ES2540453A2 ES2540453A2 (es) | 2015-07-09 |
ES2540453R1 ES2540453R1 (es) | 2016-02-23 |
ES2540453B1 true ES2540453B1 (es) | 2016-09-07 |
Family
ID=47623891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201590050A Expired - Fee Related ES2540453B1 (es) | 2012-11-30 | 2013-12-02 | Micropartículas con EGF, procedimiento de preparación y uso |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2737895A1 (es) |
ES (1) | ES2540453B1 (es) |
WO (1) | WO2014083233A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105287242A (zh) * | 2015-11-11 | 2016-02-03 | 浙江元研生物科技有限公司 | 一种含人干细胞生长因子的护肤品及其制备方法 |
CU20190022A7 (es) * | 2019-03-18 | 2020-10-20 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición farmacéutica para el tratamiento de la úlcera del pie diabético |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219998A (en) | 1990-06-04 | 1993-06-15 | Levin Robert H | Yeast-derived epidermal growth factor |
CN1720989A (zh) * | 2004-07-15 | 2006-01-18 | 深圳市清华源兴生物医药科技有限公司 | 一种表皮生长因子缓释微球及其制备方法与应用 |
CU23388B6 (es) | 2006-01-31 | 2009-07-16 | Ct Ingenieria Genetica Biotech | Composición farmacéutica de microesferas para prevenir la amputación del pie diabético |
CU23526B6 (es) * | 2006-10-03 | 2010-05-19 | Ct Ingenieria Genetica Biotech | Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética |
-
2012
- 2012-11-30 EP EP12382476.5A patent/EP2737895A1/en not_active Withdrawn
-
2013
- 2013-12-02 ES ES201590050A patent/ES2540453B1/es not_active Expired - Fee Related
- 2013-12-02 WO PCT/ES2013/070833 patent/WO2014083233A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014083233A1 (es) | 2014-06-05 |
EP2737895A1 (en) | 2014-06-04 |
ES2540453R1 (es) | 2016-02-23 |
ES2540453A2 (es) | 2015-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2533145B1 (es) | Procedimiento cosmético para reducir el tejido adiposo subcutáneo | |
BR112015030525A2 (pt) | nanopartícula, kit, método de preparação de uma nanopartícula, e uso da nanopartícula | |
EP2846714A4 (en) | METHOD AND DEVICE FOR FIXING TISSUES TO BONE, INCLUDING THE PROVISION AND USE OF A NOVEL NODLESS NEEDLE ANCHOR SYSTEM | |
EP3079604A4 (en) | Method and apparatus for attaching tissue to bone, including the provision and use of a novel knotless suture anchor system | |
CL2014000254A1 (es) | Hormona de crecimiento de accion prolongada y metodo para producir la misma | |
EP2967552B8 (en) | Tissue capturing bone anchor | |
CO6960513A2 (es) | Ancla quirúrgica | |
ES2421956B1 (es) | Nueva forma cristalina de sulfato de sitagliptina | |
EP3030176A4 (en) | Bipolar surgical instrument with tissue stop | |
DK2994173T3 (en) | Wound healing and tissue engineering | |
FR3008885B1 (fr) | Dispositif chirurgical notamment pour la pose de prothese de cordage mitrale | |
BR112015000534A2 (pt) | método para a preparação de 2,4-dihidroxibutirato, microrganismo, organismo e uso | |
BR112014028413A2 (pt) | usos terapêuticos de proteínas do fator de crescimento de fibroblastos 21 . | |
WO2014018747A3 (en) | Glycoproteins with anti-inflammatory properties | |
BR112015022347A2 (pt) | composição para vacinação, método para produzir uma composição para vacinação e uso de composição | |
UY34385A (es) | Ésteres lábiles de agroquímicos para una liberación controlada y reducción del desplazamiento fuera del sitio de acción | |
ES2567082T9 (es) | Transformador de turbina eólica | |
BR112014026565A2 (pt) | formulação, uso de uma formulação, e, processo para produzir uma formulação | |
BR112014026564A2 (pt) | formulação, uso de uma formulação, e, processo para a preparação de uma formulação | |
CL2014002908A1 (es) | Método para la preparación de 2-(2,3-dimetilfenil)-1-propanal y sus usos. | |
CL2016001369A1 (es) | Procedimiento para la preparación de un emulsionado de aceite en agua | |
ES2540453B1 (es) | Micropartículas con EGF, procedimiento de preparación y uso | |
CO7200264A2 (es) | Fluoruros de fluorpicolinoilo y procesos para su preparación | |
BR112014030949A2 (pt) | "composição, processo para o tratamento cosmético e uso de uma composição" | |
DE112014005425A5 (de) | Patiententisch zur Herstellung von NMR- und/oder CT-Aufnahmen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2540453 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160907 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20210915 |